JANUS HENDERSON GROUP PLC - 30 Sep 2025 SCHEDULE 13G/A Report for LEXEO THERAPEUTICS, INC. Common Stock (LXEO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
LEXEO THERAPEUTICS, INC. Common Stock
Symbol
LXEO
Shares outstanding
54,031,212 shares
Disclosed Ownership
6,105,527 shares
Ownership
11.3%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 12:49:19 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 11.3% 6,105,527 0 6,105,527 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 7.6% 4,076,465 0 4,076,465 Kristin Mariani Head of North America Compliance, CCO